PIK3CA mutation in metastatic colorectal cancer (mCRC): Association with clinico-pathological features and outcome

被引：0
|
作者：
Fanotto, V. [1 ]
Zucchelli, G. [2 ]
Germani, M. M. [2 ]
Rossini, D. [2 ]
Sensi, E. [3 ]
Lupi, C. [3 ]
Ugolini, C. [3 ]
Antoniotti, C. [2 ]
Marmorino, F. [2 ]
Moretto, R. [2 ]
Boccaccino, A. [2 ]
Borelli, B. [2 ]
Conca, V. [2 ]
Ongaro, E. [4 ]
Masi, G. [2 ]
Fontanini, G. [5 ]
Falcone, A. [2 ]
Cremolini, C. [2 ]
机构：
[1] Univ Udine, Dept Med DAME, Udine, Italy
[2] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[3] Azienda Osped Univ Pisana, Unit Pathol 3, Pisa, Italy
[4] CRO, IRCCS, SOC Oncol Med & Prevenz Oncol, Aviano, Italy
[5] Univ Pisa, Dept Surg Med Mol Pathol & Crit Care, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
631P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PIK3CA mutations in colorectal cancer and its relationship with clinico-pathological and molecular parameters
    Wong, Chi Wai
    Chan, Tsun Leung
    Chan, Yee Wai
    Chan, Annie Shuk Yee
    Yuen, Siu Tsan
    Leung, Suet Yi
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Clinico-pathological Features of PIK3CA Mutation in HER2-Positive Breast Cancer of Indian Population
    Saikia K.K.
    Panigrahi M.K.
    Mehta A.
    Kumar D.
    Indian Journal of Surgical Oncology, 2018, 9 (3) : 381 - 386
  • [3] PIK3CA mutation and methylation influences the outcome of colorectal cancer
    Iida, Satoru
    Kato, Shunsuke
    Ishiguro, Megumi
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Kobayashi, Hirotoshi
    Higuchi, Tetsuro
    Uetake, Hiroyuki
    Enomoto, Masayuki
    Sugihara, Kenichi
    ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570
  • [4] Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)
    Brage, E. Teran
    Tocino, R. Vidal
    Puertas, P. Reguera
    Mateos, Y. Lopez
    Gutierrez, A. Lopez
    Hernandez, M. M. Abad
    Manzano, J. Sayagues
    Rodrigues, A.
    Montero-Gonzalez, J.
    Araujo, D. Morchon
    Gonzalez, J. C. Redondo
    Mejorada, R. Lozano
    Sanchez, E. Fonseca
    ANNALS OF ONCOLOGY, 2024, 35 : S49 - S49
  • [5] Neutrophil-to-lymphocyte ratio in metastatic breast cancer: Association with clinico-pathological features and outcome
    Bartoletti, M.
    Gerratana, L.
    Zago, S.
    Basile, D.
    Vitale, M. G.
    Pelizzari, G.
    Bonotto, M.
    Bozza, C.
    Fanotto, V.
    Lisanti, C.
    Cinausero, M.
    Barban, S.
    Lera, M.
    Venuti, I.
    Mansutti, M.
    Minisini, A. M.
    Fasola, G.
    Curcio, F.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [7] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [8] Natural history and outcome of patients presenting a metastatic breast cancer with PIK3CA mutation
    Mosele, Fernanda
    Verret, Benjamin
    Lusque, Amelie
    Filleron, Thomas
    Bachelot, Thomas
    Arnedos, Monica
    Campone, Mario
    Dalenc, Florence
    Lefeuvre, Claudia
    Sablin, Marie Paule
    Bonnefoi, Herve
    Lacroix, Ludovic
    Bieche, Ivan
    Goncalves, Anthony
    Jacot, William
    Jimenez, Marta
    Jacquet, Amelie
    Andre, Fabrice
    Andre, Fabrice
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival
    Sahin, Ibrahim H.
    Garrett, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 289 - 289
  • [10] PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
    Kalinsky, Kevin
    Jacks, Lindsay M.
    Heguy, Adriana
    Patil, Sujata
    Drobnjak, Marija
    Bhanot, Umeshkumar K.
    Hedvat, Cyrus V.
    Traina, Tiffany A.
    Solit, David
    Gerald, William
    Moynahan, Mary Ellen
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5049 - 5059
12345